KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
P/S ratio for KemPharm (KMPH)
P/S ratio as of May 2024 (TTM): 19.2
According to KemPharm's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 19.1694. At the end of 2022 the company had a P/S ratio of 15.1.
P/S ratio history for KemPharm from 2015 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 15.1 | 42.3% |
| 2021 | 10.6 | 178.27% |
| 2020 | 3.82 | 256.12% |
| 2019 | 1.07 | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | 8.03 | -58.14% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | 1.82 | -90.53% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | 2.83 | -85.25% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | 0.1451 | -99.24% | 🇺🇸 USA |